Finance

Lists
IHH:KLSE
IHH Healthcare Bhd
MYR 7,89
-0,13%
(-0,010) 1D
12 Okt., 16:28:36 GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for IHH...
Open
MYR 7,87
High
MYR 7,93
Low
MYR 7,84
Mkt. cap
69,72 mjd
Avg. vol.
4,30 m
Volume
852,80 k
Dividend
1,39%
Quarterly dividend
MYR 0,03
Ex-dividend date
29 Sep. 2026
P/E ratio
31,06
52-wk high
MYR 9,58
52-wk low
MYR 7,54
EPS
MYR 0,25
Shares outstanding
8,84 mjd
No. of employees
76 k
Open
MYR 7,87
High
MYR 7,93
Low
MYR 7,84
Mkt. cap
69,72 mjd
Avg. vol.
4,30 m
Volume
852,80 k
Dividend
1,39%
Quarterly dividend
MYR 0,03
Ex-dividend date
29 Sep. 2026
P/E ratio
31,06
52-wk high
MYR 9,58
52-wk low
MYR 7,54
EPS
MYR 0,25
Shares outstanding
8,84 mjd
No. of employees
76 k
News stories
From web sources and news partners
Profile
IHH Healthcare Berhad is a multinational private healthcare group headquartered in Singapore and Kuala Lumpur, Malaysia. The group operates 190 healthcare facilities, including 89 hospitals, across 10 countries and has a workforce of 76,000 employees across Singapore, Malaysia, Turkey, India, Greater China, and other regions of Asia and Europe. It is listed on Bursa Malaysia and the Singapore Exchange. As of FY24, the largest shareholder of IHH Healthcare is Mitsui of Japan followed by the Malaysian government's sovereign wealth fund Khazanah Nasional and Citigroup of the United States. A further stake is held by the Employees Provident Fund of Malaysia. The chairman of IHH is Nik Norzrul Thani bin N Hassan Thani. Wikipedia
About IHH Healthcare Bhd
CEOPrem Kumar Nair
Employees76 k
Founded2010
Headquarters-
SectorHealth care provider
Last report
27 Aug. 2026
Fiscal period
Q2 2026
MYR 0,06 / MYR 0,06
+7,33%beat
Revenue / Est. (MYR)
7,05 mjd / 7,03 mjd
+0,26%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in MYR
Loading Previous Earnings...
Revenue
Net income
All values in MYR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
6,57 mjd
6,58 mjd
6,55 mjd
7,05 mjd
Cost of goods sold
4,33 mjd
4,34 mjd
4,43 mjd
4,76 mjd
Cost of revenue
4,33 mjd
4,34 mjd
4,43 mjd
4,76 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,00 m
47,00 m
38,00 m
38,00 m
Operating expense
1,20 mjd
1,26 mjd
1,17 mjd
1,22 mjd
Total operating expenses
5,53 mjd
5,60 mjd
5,60 mjd
5,98 mjd
Operating income
1,04 mjd
983,00 m
952,00 m
1,07 mjd
Other non operating income
-10,00 m
-21,00 m
-11,00 m
-21,00 m
EBT including unusual items
1,05 mjd
886,00 m
972,00 m
1,03 mjd
EBT excluding unusual items
808,00 m
749,00 m
743,00 m
896,00 m
Income tax expense
264,00 m
260,00 m
297,00 m
309,00 m
Effective tax rate
25,07%
29,35%
30,56%
29,94%
Other operating expenses
674,00 m
621,00 m
641,00 m
640,00 m
Net income
616,00 m
528,00 m
528,00 m
573,00 m
Net profit margin
9,38%
8,02%
8,06%
8,13%
Earnings per share
0,05
0,06
0,05
0,06
Interest and investment income
45,00 m
39,00 m
53,00 m
96,00 m
Interest expense
-269,00 m
-252,00 m
-252,00 m
-252,00 m
Net interest expenses
-224,00 m
-213,00 m
-199,00 m
-156,00 m
Depreciation and amortization charges
476,00 m
474,00 m
466,00 m
490,00 m
EBITDA
1,40 mjd
1,36 mjd
1,33 mjd
1,50 mjd
Gain or loss from assets sale
4,00 m
-3,00 m
-2,00 m
-6,00 m
AI content may include mistakes. Learn more
Google-programme